Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Accumulated Expenses (2018 - 2025)

Historic Accumulated Expenses for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $44.7 million.

  • Verastem's Accumulated Expenses rose 10187.33% to $44.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.7 million, marking a year-over-year increase of 10187.33%. This contributed to the annual value of $26.0 million for FY2024, which is N/A changed from last year.
  • Verastem's Accumulated Expenses amounted to $44.7 million in Q3 2025, which was up 10187.33% from $38.1 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Accumulated Expenses registered a high of $44.7 million during Q3 2025, and its lowest value of $8.8 million during Q1 2021.
  • Its 5-year average for Accumulated Expenses is $19.1 million, with a median of $16.0 million in 2021.
  • In the last 5 years, Verastem's Accumulated Expenses tumbled by 5109.38% in 2021 and then soared by 12178.54% in 2025.
  • Over the past 5 years, Verastem's Accumulated Expenses (Quarter) stood at $15.6 million in 2021, then dropped by 4.08% to $15.0 million in 2022, then grew by 8.88% to $16.3 million in 2023, then skyrocketed by 59.08% to $26.0 million in 2024, then skyrocketed by 72.32% to $44.7 million in 2025.
  • Its Accumulated Expenses stands at $44.7 million for Q3 2025, versus $38.1 million for Q2 2025 and $25.4 million for Q1 2025.